Brief: HBM Says Swixx Biopharma Announces EUR 45 Mln Capital Increase

HBM Healthcare Investments AG

28/05/2021 06:17

May 28 (Reuters) - HBM HEALTHCARE INVESTMENTS AG  HBMN.S :
    * HBM PORTFOLIO COMPANY SWIXX BIOPHARMA ANNOUNCES EUR 45
MILLION
CAPITAL INCREASE
    * UNDER TERMS OF AGREEMENT, MÉRIEUX EQUITY PARTNERS WILL
INVEST
EUR 40 MILLION FOR A MINORITY STAKE IN SWIXX
    * HBM HEALTHCARE INVESTMENTS, WHO IS AN INVESTOR IN SWIXX
SINCE
2017, PARTICIPATES WITH EUR 5 MILLION IN CAPITAL INCREASE

Source text for Eikon:  ID:nEQvlhq7a 
Further company coverage:  HBMN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))